The shocking allegations surrounding the Oxevision camera-based monitoring system, used in over 40% of NHS mental health trusts, have sparked a major investigation by the Information Commissioner's Office (ICO). At the heart of this probe is a worrying concern that patient privacy and data protection are being compromised. Patients themselves have described the experience as 'creepy' and 'spying', highlighting the need for reassurance about how their personal information is being handled.
Oxevision, developed by Oxehealth (now rebranded as LIO), uses cameras and infrared sensors to monitor patients in their bedrooms remotely. While the company claims this technology enhances patient safety and frees up NHS staff time, campaigners have raised concerns that it may be breaching data protection laws. They argue that patients' bedrooms should remain a sanctuary where privacy is respected, and any data collection must be lawful, with consent properly obtained and easily withdrawable.
The controversy has been further exacerbated by the ongoing Lampard inquiry into thousands of deaths of mental health patients in Essex. The case of Sophie Alderman, 27, who tragically took her own life while under Oxevision surveillance, highlights the potential risks associated with this technology. Her mother, Tammy Smith, testified to the inquiry that the system was intrusive and contributed to her daughter's paranoia, stating that Sophie felt 'under a microscope' due to the camera's presence.
Selen Cavcav from Inquest, who is supporting the Alderman family, stressed that individuals in mental health settings require compassionate care, not isolation and surveillance. She warned that technologies like Oxevision could exacerbate emotional distress and existing issues such as coercive treatment and a lack of privacy. Solicitor Nina Ali, representing over 150 families at the Lampard inquiry, described Oxevision's use in Essex as 'unsafe, intrusive, and potentially unlawful', raising concerns about its potential to cause more harm than good.
Laura Cozens, head of patient safety at LIO, acknowledged that filming patients 24 hours a day constitutes a significant privacy invasion. However, she stated that video recordings are only accessible under strict governance on request. The ICO's investigation into Oxehealth/LIO has yet to provide further details, but its outcome could have significant implications for the deployment of similar technologies across NHS trusts.
The Lampard inquiry is set to hear more evidence next month regarding Oxevision's use within mental health wards at the Essex Partnership University NHS Trust (EPUT). A thorough examination of this case is crucial in determining whether such technologies are truly beneficial or pose a risk to patient well-being and safety. The ICO's investigation will undoubtedly shed light on these concerns, providing essential guidance for NHS trusts and healthcare providers.